NeuroSense Therapeutics Ltd. Shares Outstanding (Cover Page)
NeuroSense Therapeutics Ltd. (NRSN) had Shares Outstanding (Cover Page) of 32.56 million shares as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
dei:EntityCommonStockSharesOutstanding · last filed 2026-03-31
- 2025-12-31: Entity Common Stock, Shares Outstanding 32.56M shares.
- 2024-12-31: Entity Common Stock, Shares Outstanding 23.23M shares.
- 2023-12-31: Entity Common Stock, Shares Outstanding 15.38M shares.
- 2022-04-13: Entity Common Stock, Shares Outstanding 11.78M shares; Entity Common Stock, Shares Outstanding as first filed 10.94M shares.
| Period end | Entity Common Stock, Shares Outstanding | Entity Common Stock, Shares Outstanding as first filed |
|---|---|---|
| 2025-12-31 | 32.56M shares 20-F · filed 2026-03-31 | |
| 2024-12-31 | 23.23M shares 20-F · filed 2025-04-07 | |
| 2023-12-31 | 15.38M shares 20-F · filed 2024-04-04 | |
| 2022-04-13 | 11.78M shares 20-F · filed 2023-03-22 | 10.94M shares 20-F · filed 2022-04-14 |